Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Amgen, Inc. (NQ: AMGN)
104.24 USD  +2.06 (+2.02%)
Official Closing Price  /  Updated: 5:20 PM EDT, May 21, 2013  /  Add to My Watchlist      
View: Quote News Research
Press releases about Amgen, Inc.
 
< Previous 1 2 3 4 5 6 7 8 9
...
35 36 Next >
A Tribute to George Rathmann, Amgen's Founding CEO (1927-2012)
April 23, 2012
from PR Newswire
Amgen Announces Webcast of 2012 First Quarter Financial Results
April 19, 2012
from PR Newswire
RBCC and N3D Forge Ahead with Bold Growth Strategy
April 13, 2012
from Business Wire News Releases
RBCC: New N3D Prototype Could be the Beginning of Something Big
April 12, 2012
from Business Wire News Releases
Amgen to Acquire Privately Held KAI Pharmaceuticals
April 10, 2012
Acquisition Includes KAI-4169 Program, Which Delivered Compelling Phase 2a Clinical Results for the Treatment of Secondary Hyperparathyroidism in Patients with Chronic Kidney Disease who are on... Read More
from PR Newswire
RBCC: Global Market for Neurodegenerative Therapies to Exceed $43.4 Billion by 2015
April 10, 2012
from Business Wire News Releases
UCB and Amgen Initiate Sclerostin Antibody Phase 3 Program in Patients With Postmenopausal Osteoporosis
April 04, 2012
First Patient Randomized Marks Start of Phase 3 Program to Evaluate Safety and Efficacy of CDP7851/AMG 785 in Women With Postmenopausal Osteoporosis Read More
from PR Newswire
Amgen and AstraZeneca Announce Collaboration to Jointly Develop and Commercialize Clinical-Stage Inflammation Portfolio
April 02, 2012
Collaboration Comprises Five Monoclonal Antibodies Read More
from PR Newswire
Amgen Announces Phase 2 Study Results for Brodalumab in Moderate to Severe Plaque Psoriasis Published in the New England Journal of Medicine
March 28, 2012
Brodalumab Moving Into Phase 3 for Moderate to Severe Psoriasis Read More
from PR Newswire
Amgen's PCSK9 Inhibitor Reduced LDL Cholesterol up to 81 Percent in Phase 1b Study
March 25, 2012
Robust AMG 145 Phase 2 Program Expected to Deliver Results in 2012 Read More
from PR Newswire
RBCC Prepares to Join the $3 Billion Fight Against Parkinson’s Disease
March 23, 2012
from Business Wire News Releases
Amgen Announces 2012 Second Quarter Dividend
March 15, 2012
from PR Newswire
RBCC: Promising New Parkinson’s Therapies May Also Treat Brain Injuries
March 14, 2012
from Business Wire News Releases
RBCC Identifies Promising New Business Targets at Texas’ Premiere Life Sciences Forum
March 12, 2012
from Business Wire News Releases
Amgen Completes Tender Offer for Outstanding Shares of Micromet, Inc.
March 07, 2012
from PR Newswire
Schwartz Center Receives $500,000 Grant from the Amgen Foundation
March 06, 2012
Funds Support Expanded Efforts to Make Compassionate, Patient-Centered Care a National Healthcare Priority Read More
from PR Newswire
Amgen Announces Initial Results of Tender Offer for Outstanding Shares of Micromet, Inc. and Commencement of Subsequent Offering Period
March 02, 2012
from PR Newswire
Amgen to Present at the Cowen and Company 32nd Annual Healthcare Conference
February 29, 2012
from PR Newswire
Amgen to Present at the Citi 2012 Global Healthcare Conference
February 23, 2012
from PR Newswire
Dako Enters into an Additional Collaboration with Amgen on Developing a Companion Diagnostic Test (pharmDxTM) for an Investigational Cancer Therapy in Clinical Development
February 20, 2012
from Marketwired News Releases
Dako Enters Into an Additional Collaboration With Amgen on Developing a Companion Diagnostic Test (pharmDx(TM)) for an Investigational Cancer Therapy in Clinical Development
February 20, 2012
from Marketwired News Releases
RBCC Sets Sights on Top Emerging Biotech Innovations
February 17, 2012
from Business Wire News Releases
Amgen and Micromet Announce Early Termination of HSR Waiting Period for Amgen's Acquisition of Micromet
February 15, 2012
from PR Newswire
Amgen Names Michael Severino, M.D., Senior Vice President, Global Development and Corporate Chief Medical Officer
February 14, 2012
from PR Newswire
Amgen to Present at the Leerink Swann Global Healthcare Conference
February 13, 2012
from PR Newswire
Amgen to Discuss Application for New Use of XGEVA® (denosumab) at FDA Oncologic Drugs Advisory Committee Meeting
February 08, 2012
from PR Newswire
Equity Research on Amgen Inc. and Biogen Idec Inc. - Biotech Industry Growing
February 02, 2012
from Marketwired News Releases
Research Reports for Day Traders: Newell Rubbermaid, Apple, Amgen, Lowe's, Itau Unibanco Holding and Chevron
January 30, 2012
from PR Newswire
Faruqi & Faruqi, LLP Announces Investigation of Micromet, Inc.
January 28, 2012
from Business Wire News Releases
The Law Firm of Weiss & Lurie Investigates Micromet, Inc.
January 27, 2012
from Business Wire News Releases
< Previous 1 2 3 4 5 6 7 8 9
...
35 36 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here